i
Superseded
This Document Has Been Replaced By:
i
Retired
This Document Has Been Retired
i
Up-to-date Information
This is the latest update:
R292K Substitution and Drug Susceptibility of Influenza A(H7N9) Viruses
-
Published Date:
2013
-
Publisher's site:
-
Source:Emerg Infect Dis. 19(9):1521-1524.
-
Language:
-
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Neuraminidase inhibitors are the only licensed antiviral medications available to treat avian influenza A(H7N9) virus infections in humans. According to a neuraminidase inhibition assay, an R292K substitution reduced antiviral efficacy of inhibitors, especially oseltamivir, and decreased viral fitness in cell culture. Monitoring emergence of R292K-carrying viruses using a pH-modified neuraminidase inhibition assay should be considered.
-
Subject:
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
text/plain text/plain
No Related Documents.